Canada Markets closed

Canntab Therapeutics Limited (CTABF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
At close: 11:09AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.8377
52 Week Low 30.1854
50-Day Moving Average 30.3405
200-Day Moving Average 30.4921

Share Statistics

Avg Vol (3 month) 3405
Avg Vol (10 day) 3260
Shares Outstanding 537.32M
Implied Shares Outstanding 6N/A
Float 831.98M
% Held by Insiders 127.56%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 19, 2018
Ex-Dividend Date 4Mar 07, 2016
Last Split Factor 21:200
Last Split Date 3Apr 19, 2018

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends May 30, 2021
Most Recent Quarter (mrq)Feb 27, 2022


Profit Margin 0.00%
Operating Margin (ttm)710.10%

Management Effectiveness

Return on Assets (ttm)-43.71%
Return on Equity (ttm)-205.56%

Income Statement

Revenue (ttm)-589.55k
Revenue Per Share (ttm)-0.02
Quarterly Revenue Growth (yoy)-89.60%
Gross Profit (ttm)-263.31k
Net Income Avi to Common (ttm)-4.55M
Diluted EPS (ttm)-0.0910
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.5M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)2.57M
Total Debt/Equity (mrq)243.28
Current Ratio (mrq)1.20
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-3.08M
Levered Free Cash Flow (ttm)-1.46M